Subtotal: $110.00
Intrinsicly evisculate emerging cutting edge scenarios redefine future-proof e-markets demand line
CEFUROXIME
* Higher stability to beta-lactamase hydrolysis than first generation cephalosporins.
* Produces Clinical and bacteriological efficacy equivalent to that of amoxicillin/clavulanic acid in treatment of lower respiratory tract infections.
• Potent inhibitor of B-lactamase which enhance the activity of cefuroxime.
Pharyngitis/Tonsillitis
Acute Bacterial Otitis Media
Acute Bacterial Exacerbations of
Chronic Bronchitis
Uncomplicated and Complicated
Skin-structure Infections
Uncomplicated Urinary Tract Infection
Uncomplicated Gonorrhea
Gravianz Pharma © 2025. All Rights Reserved.
Designed and Maintained by iShape Solution
